Compare Stocks: CVS, XLV, PIPR, MS, and UBS

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CVS CVS Health	$93.15 +0.2%	$101.42	$69.51 ▼ $110.68	$119.02B	0.61	7.84 million shs	3.99 million shs
MS Morgan Stanley	$214.69 -0.1%	$216.44	$145.65 ▼ $232.25	$338.75B	1.22	4.27 million shs	3.73 million shs
PIPR Piper Sandler Companies	$75.54 +1.2%	$75.28	$68.70 ▼ $95.07	$5.34B	1.43	475,210 shs	532,909 shs
UBS UBS Group	$54.94 +1.1%	$52.44	$36.29 ▼ $55.15	$171.51B	1.18	1.46 million shs	1.73 million shs
XLV Health Care Select Sector SPDR Fund	$171.16 -0.2%	$164.03	$133.73 ▼ $176.60	$44.09B	0.56	11.65 million shs	4.88 million shs

10 Stocks Powering The Next AI Boom

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CVS CVS Health	0.00%	+0.15%	-11.46%	+2.40%	+29.49%
MS Morgan Stanley	0.00%	+0.13%	+2.24%	+3.34%	+43.66%
PIPR Piper Sandler Companies	0.00%	+0.55%	-1.12%	-3.57%	-10.62%
UBS UBS Group	0.00%	+3.13%	+2.97%	+16.64%	+36.60%
XLV Health Care Select Sector SPDR Fund	0.00%	-1.98%	+4.67%	+14.51%	+24.96%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CVS CVS Health	$93.15 +0.2%	$101.42	$69.51 ▼ $110.68	$119.02B	0.61	7.84 million shs	3.99 million shs
MS Morgan Stanley	$214.69 -0.1%	$216.44	$145.65 ▼ $232.25	$338.75B	1.22	4.27 million shs	3.73 million shs
PIPR Piper Sandler Companies	$75.54 +1.2%	$75.28	$68.70 ▼ $95.07	$5.34B	1.43	475,210 shs	532,909 shs
UBS UBS Group	$54.94 +1.1%	$52.44	$36.29 ▼ $55.15	$171.51B	1.18	1.46 million shs	1.73 million shs
XLV Health Care Select Sector SPDR Fund	$171.16 -0.2%	$164.03	$133.73 ▼ $176.60	$44.09B	0.56	11.65 million shs	4.88 million shs

10 Stocks Powering The Next AI Boom

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CVS CVS Health	0.00%	+0.15%	-11.46%	+2.40%	+29.49%
MS Morgan Stanley	0.00%	+0.13%	+2.24%	+3.34%	+43.66%
PIPR Piper Sandler Companies	0.00%	+0.55%	-1.12%	-3.57%	-10.62%
UBS UBS Group	0.00%	+3.13%	+2.97%	+16.64%	+36.60%
XLV Health Care Select Sector SPDR Fund	0.00%	-1.98%	+4.67%	+14.51%	+24.96%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CVS CVS Health	2.92	Moderate Buy	$107.17	15.05% Upside
MS Morgan Stanley	2.65	Moderate Buy	$224.75	4.69% Upside
PIPR Piper Sandler Companies	2.33	Hold	$95.06	25.84% Upside
UBS UBS Group	2.36	Hold	$60.30	9.76% Upside
XLV Health Care Select Sector SPDR Fund	2.76	Moderate Buy	$171.16	N/A

Current Analyst Ratings Breakdown

Latest CVS, XLV, PIPR, MS, and UBS Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/26/2026	CVS CVS Health	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Overweight
8/24/2026	MS Morgan Stanley	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
8/19/2026	CVS CVS Health	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$104.00 ➝ $114.00
8/17/2026	PIPR Piper Sandler Companies	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold (C+)
8/12/2026	CVS CVS Health	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$111.00 ➝ $118.00
8/6/2026	CVS CVS Health	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$107.00
8/6/2026	CVS CVS Health	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$122.00 ➝ $126.00
8/6/2026	CVS CVS Health	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$106.00 ➝ $108.00
8/5/2026	CVS CVS Health	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C+) ➝ Buy (B-)
8/5/2026	MS Morgan Stanley	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Buy (B-) ➝ Buy (B)
8/5/2026	UBS UBS Group	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Outperform

(Data available from 8/30/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CVS CVS Health	$402.07B	0.30	$14.90 per share	6.25	$62.47 per share	1.49
MS Morgan Stanley	$119.66B	2.83	$13.54 per share	15.86	$68.28 per share	3.14
PIPR Piper Sandler Companies	$1.90B	2.80	$5.23 per share	14.43	$22.18 per share	3.41
UBS UBS Group	$76.12B	2.25	$3.62 per share	15.18	$28.63 per share	1.92
XLV Health Care Select Sector SPDR Fund	N/A	N/A	N/A	N/A	N/A	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CVS CVS Health	$1.77B	$3.78	24.64	10.97	0.91	1.18%	13.12%	3.95%	11/4/2026 (Estimated)
MS Morgan Stanley	$16.86B	$12.37	17.36	16.44	1.52	15.65%	19.31%	1.33%	10/14/2026 (Estimated)
PIPR Piper Sandler Companies	$281.33M	$4.32	17.51	14.15	1.75	14.51%	21.92%	14.60%	10/30/2026 (Estimated)
UBS UBS Group	$7.77B	$2.94	18.69	13.05	0.82	13.10%	10.50%	0.57%	10/28/2026 (Estimated)
XLV Health Care Select Sector SPDR Fund	N/A	N/A	21.15	N/A	N/A	N/A	N/A	N/A	N/A

Latest CVS, XLV, PIPR, MS, and UBS Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/5/2026	Q2 2026	CVS CVS Health	$1.87	$2.58	+$0.71	$2.31	$100.03 billion	$106.10 billion
7/30/2026	Q2 2026	PIPR Piper Sandler Companies	$0.8750	$1.04	+$0.1650	$0.95	$445.28 million	$491.14 million
7/29/2026	Q2 2026	UBS UBS Group	$0.90	$0.87	-$0.03	$0.87	$13.40 billion	$13.35 billion
7/15/2026	Q2 2026	MS Morgan Stanley	$2.89	$3.46	+$0.57	$3.46	$19.67 billion	$21.35 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
CVS CVS Health	$2.66	2.86%	+5.87%	70.37%	4 Years
MS Morgan Stanley	$4.60	2.14%	+22.42%	37.19%	12 Years
PIPR Piper Sandler Companies	$0.80	1.06%	+23.39%	18.52%	1 Years
UBS UBS Group	$0.36	0.66%	-100.00%	12.24%	5 Years
XLV Health Care Select Sector SPDR Fund	$2.53	1.48%	N/A	N/A	N/A

Latest CVS, XLV, PIPR, MS, and UBS Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/30/2026	PIPR Piper Sandler Companies	quarterly	$0.20	1.06%	8/28/2026	8/28/2026	9/11/2026
7/15/2026	MS Morgan Stanley	quarterly	$1.15	2.18%	7/31/2026	7/31/2026	8/14/2026
7/10/2026	CVS CVS Health	quarterly	$0.6650	2.49%	7/23/2026	7/23/2026	8/3/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CVS CVS Health	0.74	0.87	0.66
MS Morgan Stanley	3.65	0.79	0.79
PIPR Piper Sandler Companies	N/A	1.41	0.67
UBS UBS Group	3.84	1.02	1.19
XLV Health Care Select Sector SPDR Fund	N/A	N/A	N/A

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CVS CVS Health	80.66%
MS Morgan Stanley	84.19%
PIPR Piper Sandler Companies	72.79%
UBS UBS Group	N/A
XLV Health Care Select Sector SPDR Fund	N/A

Insider Ownership

Company	Insider Ownership
CVS CVS Health	0.85%
MS Morgan Stanley	0.17%
PIPR Piper Sandler Companies	3.10%
UBS UBS Group	1.00%
XLV Health Care Select Sector SPDR Fund	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CVS CVS Health	300,000	1.28 billion	1.27 billion	Optionable
MS Morgan Stanley	82,992	1.58 billion	1.57 billion	Optionable
PIPR Piper Sandler Companies	1,858	70.67 million	68.48 million	N/A
UBS UBS Group	103,177	3.12 billion	3.09 billion	Optionable
XLV Health Care Select Sector SPDR Fund	N/A	257.57 million	N/A	Not Optionable

CVS, XLV, PIPR, MS, and UBS Headlines

Recent News About These Companies

FDA Nods Lilly-Roche's Alzheimer's Blood Test: Healthcare ETFs to Track Now

August 27 at 11:31 AM | zacks.com

Should You Invest in the State Street Health Care Select Sector SPDR ETF ETF (XLV)?

August 26, 2026 | zacks.com

Healthcare Is Rising: XLV Is A Better Option For Investors Than BME

August 24, 2026 | seekingalpha.com

Healthcare ETFs Are Looking Up: Here's Why

August 19, 2026 | zacks.com

Likely ETF & Stock Winners From July Jobs Report

August 11, 2026 | zacks.com

Sector ETFs Post Record $25B Inflow as Tech Leads

August 10, 2026 | etftrends.comE

Vanguard Health Care ETF vs State Street XLV: Which ETF Is the Better Buy for Investors in 2026?

August 8, 2026 | fool.com

Broad Market Momentum & Defensive Pivots: This Week's Top ETF Flows

August 7, 2026 | etftrends.comE

4 Healthcare Stocks to Watch as Defensive Demand Strengthens

August 7, 2026 | zacks.com

State Street XLV vs VanEck BBH: Which Healthcare ETF Is the Better Buy in 2026?

August 5, 2026 | finance.yahoo.com

Showstopper Healthcare Earnings Elevate Use Case for XLV

August 5, 2026 | etftrends.comE

Short Interest Alert: Most and least shorted sub-$2B healthcare stocks in July 2026

August 3, 2026 | seekingalpha.com

Which Is the Better State Street Healthcare ETF: The Broad XLV or the Biotech XBI?

August 3, 2026 | fool.com

XLV vs. IBBQ: Is Broad Healthcare Exposure or Biotech Growth the Better ETF Buy?

August 1, 2026 | fool.com

XLV vs PBE: Is a Low-Cost Healthcare ETF the Better Buy Than a Focused Biotech Specialist?

August 1, 2026 | fool.com

XLV vs. IHE: Which Healthcare ETF Is the Better Buy?

July 31, 2026 | finance.yahoo.com

Financial Sector ETF Hits Record High on Fintech Gains

July 28, 2026 | etftrends.comE

UnitedHealth Pulls Back Post 52-Week High: Healthcare ETFs to Watch

July 27, 2026 | zacks.com

XLV vs FHLC: Which Healthcare ETF Fits Your Portfolio?

July 27, 2026 | finance.yahoo.com

PINK vs. XLV: How Do These Two Health Care ETFs Match Up?

July 26, 2026 | fool.com

These Stocks Could Be the Biggest Winners of the 2026 Midterms (XLV)

...

May 18, 2026 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

CVS, XLV, PIPR, MS, and UBS Company Descriptions

CVS Health NYSE:CVS

$93.15 +0.23 (+0.25%)

As of 08/28/2026 03:58 PM Eastern

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.

Morgan Stanley NYSE:MS

$214.69 -0.17 (-0.08%)

As of 08/28/2026 03:58 PM Eastern

Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. It operates through Institutional Securities, Wealth Management, and Investment Management segments. The Institutional Securities segment offers capital raising and financial advisory services, including services related to the underwriting of debt, equity, and other securities, as well as advice on mergers and acquisitions, restructurings, real estate, and project finance. This segment also provides equity and fixed income products comprising sales, financing, prime brokerage, and market-making services; foreign exchange and commodities; corporate and commercial real estate loans, commercial mortgage and secured lending facilities, and financing for sales and trading customers, and asset-backed and mortgage lending; and wealth management services, investment, and research services. The Wealth Management segment offers financial advisor-led brokerage, custody, administrative, and investment advisory services; self-directed brokerage services; financial and wealth planning services; workplace services, including stock plan administration; annuity and insurance products; securities-based lending, residential real estate loans, and other lending products; banking; and retirement plan services to individual investors and small to medium-sized businesses and institutions. The Investment Management segment provides equity, fixed income, alternatives and solutions, and liquidity and overlay services to benefit/defined contribution plans, foundations, endowments, government entities, sovereign wealth funds, insurance companies, third-party fund sponsors, corporations, and individuals through institutional and intermediary channels. The company was founded in 1924 and is headquartered in New York, New York.

Piper Sandler Companies NYSE:PIPR

$75.54 +0.90 (+1.21%)

As of 08/28/2026 03:58 PM Eastern

Piper Sandler Companies operates as an investment bank and institutional securities firm that serves corporations, private equity groups, public entities, non-profit entities, and institutional investors in the United States and internationally. The company offers investment banking and institutional sales, trading, and research services for various equity and fixed income products. It provides advisory services, such as mergers and acquisitions, equity private placements, and debt and restructuring advisory; raises capital through equity and debt financings; underwrites municipal issuances; and offers municipal financial advisory and loan placement services, as well as various over-the-counter derivative products. The company also offers public finance investment banking services that focus on state and local governments, and cultural and social service non-profit entities, as well as the education, healthcare, hospitality, senior living, and transportation sectors. In addition, it provides equity and fixed income advisory and trade execution services for institutional investors, and government and non-profit entities. Further, the company is involved in the alternative asset management funds merchant banking and healthcare to invest firm capital and to manage capital from outside investors, as well as trading activities. The company was formerly known as Piper Jaffray Companies and changed its name to Piper Sandler Companies in January 2020. Piper Sandler Companies was founded in 1895 and is headquartered in Minneapolis, Minnesota.

UBS Group NYSE:UBS

$54.94 +0.58 (+1.07%)

As of 08/28/2026 03:58 PM Eastern

UBS Group AG provides financial advice and solutions to private, institutional, and corporate clients worldwide. It operates through five divisions: Global Wealth Management, Personal & Corporate Banking, Asset Management, Investment Bank, and Non-core and Legacy. The company offers investment advice, estate and wealth planning, investing, corporate and banking, and investment management, as well as mortgage, securities-based, and structured lending solutions. It also provides personal banking products and services, such as deposits, credit and debit cards, and online and mobile banking, as well as lending, investments, retirement, and wealth management services; and corporate and institutional solutions, including equity and debt capital markets, syndicated and structured credit, private placements, leasing, traditional financing, and transaction banking solutions for payment and cash management services, trade and export finance, and global custody solutions. In addition, the company offers equities, fixed income, hedge funds, real estate and private markets, indexed and alternative beta strategies, asset allocation and currency investment strategies, customized multi-asset solutions, advisory and fiduciary services, and multi-manager hedge fund solutions and advisory services. Further, it advises clients on strategic business opportunities and helps them raise capital to fund their activities; enables its clients to buy, sell, and finance securities on capital markets and to manage their risks and liquidity; distributes, trades in, finances, and clears cash equities and equity-linked products; structures, originates, and distributes new equity and equity-linked issues; and originates, distributes, manages risk, and provides liquidity in foreign exchange, rates, credit and precious metals. The company was formerly known as UBS AG and changed its name to UBS Group AG in December 2014. UBS Group AG was founded in 1862 and is headquartered in Zurich, Switzerland.

Health Care Select Sector SPDR Fund NYSEARCA:XLV

$171.16 -0.42 (-0.24%)

As of 08/28/2026 04:10 PM Eastern

Health Care Select Sector SPDR Fund (the Fund) seeks to closely match the returns and characteristics of the S&P Health Care Select Sector Index (the Index). The companies included in the Index are selected on the basis of general industry classification from a universe of companies defined by the Standard & Poor's 500 Composite Stock Index (S&P 500). The Health Care Select Sector Index includes companies from the industries, such as pharmaceuticals, healthcare providers and services, healthcare equipment and supplies, biotechnology, life sciences tools and services, and healthcare technology. Under normal market conditions, the Fund generally invests substantially all, but at least 95%, of its total assets in the securities comprising the Index. State Street Global Advisors acts as the Fund's investment manager.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest CVS, XLV, PIPR, MS, and UBS Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest CVS, XLV, PIPR, MS, and UBS Earnings

Compare Dividends

Latest CVS, XLV, PIPR, MS, and UBS Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

CVS, XLV, PIPR, MS, and UBS Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

CVS, XLV, PIPR, MS, and UBS Company Descriptions

CVS Health NYSE:CVS

Morgan Stanley NYSE:MS

Piper Sandler Companies NYSE:PIPR

UBS Group NYSE:UBS

Health Care Select Sector SPDR Fund NYSEARCA:XLV

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools